A case of complete remission of advanced hepatocellular carcinoma with type III portal vein tumor thrombosis treated using transarterial chemoembolization with microspheres and radiation therapy

被引:1
作者
Fukushima, Daizo [1 ]
Imai, Shigeki [2 ]
Nishino, Noriyuki [1 ]
Hamada, Kohichi [3 ]
Horikawa, Yoshinori [1 ]
Shiwa, Yoshiki [1 ]
Nishida, Shinya [1 ]
Koyanagi, Ryota [3 ]
Wada, Hitoshi [4 ]
Sakuma, Hideo [5 ]
机构
[1] Southern Tohoku Gen Hosp, Dept Gastroenterol, 7-115 Yatsuyamada, Koriyama, Fukushima 9638563, Japan
[2] Southern Tohoku Res Inst Neurosci, Dept Radiol, 7-115 Yatsuyamada, Koriyama, Fukushima 9638563, Japan
[3] Fukushima Med Univ, Dept Minimally Invas Surg & Med Oncol, Fukushima 9601295, Japan
[4] Southern Tohoku Proton Therapy Ctr, Dept Radiat Oncol, 7-172 Yatsuyamada, Koriyama, Fukushima 9638052, Japan
[5] Southern Tohoku Res Inst Neurosci, Dept Pathol, 7-115 Yatsuyamada, Koriyama, Fukushima 9638563, Japan
关键词
Hepatocellular carcinoma; Portal vein tumor thrombosis; Arterio-portal shunt; Transarterial chemoembolization; Radiation therapy; DRUG-ELUTING BEADS; ARTERIOPORTAL SHUNT; EFFICACY; SAFETY;
D O I
10.1007/s12328-020-01124-5
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Portal vein tumor thrombosis (PVTT) is an extremely locally advanced form of hepatocellular carcinoma. The natural median survival time of patients with hepatocellular carcinoma with PVTT is 2.7 to 4.0 months. A 63-year-old woman visited our clinic complaining of abdominal distention and appetite loss, which she had had for 3 weeks prior to admission. A contrast-enhanced computed tomography scan showed double hepatocellular carcinomas with Type III PVTT and massive ascites caused by arterio-portal shunts within the PVTT. The ascites could not be treated by concentrated ascites reinfusion therapy or diuretics. Transarterial embolization using microspheres followed by radiation therapy against PVTT and five courses of transarterial chemoembolization using microspheres and cisplatin led to the maintaining of complete remission of both ascites and tumors for over 12 months after treatment. Fluoroglucose accumulation of PVTT showed 11.2 as a maximum standard uptake value on positron emission tomography before treatment. No fluoroglucose accumulation within PVTT was observed for over 12 months following treatment. Transarterial chemoembolization using microspheres followed by radiation therapy against Type III PVTT may result in drastic anti-cancer effects and improvement of both serum albumin and intractable ascites after treatment of arterio-portal shunts within the PVTT causing portal hypertension.
引用
收藏
页码:847 / 854
页数:8
相关论文
共 50 条
[41]   Hepatocellular Carcinoma With Portal Vein Tumor Thrombus Treated With Transarterial Chemoembolization and Sorafenib vs. 125Iodine Implantation [J].
Hu, Hong-Tao ;
Luo, Jun-Peng ;
Cao, Guang-Shao ;
Li, Zhen ;
Jiang, Ming ;
Guo, Chen-Yang ;
Yuan, Hang ;
Yao, Quan-Jun ;
Geng, Xiang ;
Park, Jung-Hoon ;
Cheng, Hong-Tao ;
Jiang, Li ;
Ma, Jun-Li ;
Zhao, Yan ;
Li, Hai-Liang .
FRONTIERS IN ONCOLOGY, 2021, 11
[42]   Transarterial chemoembolization in a patient with recurrent hepatocellular carcinoma and portal vein thrombosis - A case report and review of the literature [J].
Sikander, A ;
Sadashiv, S ;
Ronald, S ;
Milind, J .
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2005, 28 (06) :638-639
[43]   Comparison of intra-arterial chemoembolization with and without radiotherapy for advanced hepatocellular carcinoma with portal vein tumor thrombosis: a meta-analysis [J].
Zhao, Qianqian ;
Zhu, Kunli ;
Yue, Jinbo ;
Qi, Zhonghua ;
Jiang, Shumei ;
Xu, Xiaoqing ;
Feng, Rui ;
Wang, Renben .
THERAPEUTICS AND CLINICAL RISK MANAGEMENT, 2017, 13 :21-31
[44]   Transarterial chemoembolization versus best supportive care for patients with hepatocellular carcinoma with portal vein tumor thrombus : a multicenter study [J].
Xiang, Xiao ;
Lau, Wan Yee ;
Wu, Zhen-Yu ;
Zhao, Chao ;
Ma, Yi-Long ;
Xiang, Bang-De ;
Zhu, Ji-Ye ;
Zhong, Jian-Hong ;
Li, Le-Qun .
EJSO, 2019, 45 (08) :1460-1467
[45]   Portal vein thrombosis and arterioportal shunts: Effects on tumor response after chemoembolization of hepatocellular carcinoma [J].
Vogl, Thomas J. ;
Nour-Eldin, Nour-Eldin ;
Emad-Eldin, Sally ;
Naguib, Nagy N. N. ;
Trojan, Joerg ;
Ackermann, Hans ;
Abdelaziz, Omar .
WORLD JOURNAL OF GASTROENTEROLOGY, 2011, 17 (10) :1267-1275
[46]   Hepatic Arterial Infusion Chemotherapy Using Oxaliplatin Plus 5-Fluorouracil Versus Transarterial Chemoembolization/Embolization for the Treatment of Advanced Hepatocellular Carcinoma with Major Portal Vein Tumor Thrombosis [J].
Jungang Hu ;
Quan Bao ;
Guang Cao ;
Xu Zhu ;
Renjie Yang ;
Xinqiang Ji ;
Liang Xu ;
Kanglian Zheng ;
Weiliang Li ;
Baocai Xing ;
Xiaodong Wang .
CardioVascular and Interventional Radiology, 2020, 43 :996-1005
[47]   Prognosis of patients with hepatocellular carcinoma and portal vein tumor thrombus treated with combination of transarterial chemoembolization and palliative thermal ablation [J].
Zhou, Qunfang ;
An, Yongcheng ;
Liu, Ting ;
Liu, Zishan ;
Li, Ruixia ;
Wang, Chenmeng ;
Zhou, Feng ;
Liu, Congjuan ;
Zhu, Kangshun .
INTERNATIONAL JOURNAL OF HYPERTHERMIA, 2022, 39 (01) :97-107
[48]   Efficacy and toxicity of SBRT in advanced hepatocellular carcinoma with portal vein tumor thrombosis - a retrospective study [J].
Kumar, Rishabh ;
Yadav, Hanuman Prasad ;
Thaper, Deepak ;
Kamal, Rose ;
Gupta, Anil ;
Kirti, S. .
REPORTS OF PRACTICAL ONCOLOGY AND RADIOTHERAPY, 2021, 26 (04) :573-581
[49]   Management strategies for advanced hepatocellular carcinoma with portal vein tumor thrombosis [J].
Park, Jeayeon ;
Yu, Su Jong .
EWHA MEDICAL JOURNAL, 2025, 48 (01) :18-24
[50]   Apatinib Combined With Transarterial Chemoembolization in Patients With Hepatocellular Carcinoma and Portal Vein Tumor Thrombus: A Multicenter Retrospective Study [J].
Fan, Wenzhe ;
Yuan, Guosheng ;
Fan, Huishuang ;
Li, Fuliang ;
Wu, Yanqin ;
Zhao, Yue ;
Yao, Wang ;
Wang, Yu ;
Xue, Miao ;
Yang, Jianyong ;
Li, Jiaping .
CLINICAL THERAPEUTICS, 2019, 41 (08) :1463-1476